These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20601378)

  • 1. Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia.
    Kaya Z; Yildiz E; Gursel T; Albayrak M; Kocak U; Karadeniz C; Dalgiç B
    J Trop Pediatr; 2011 Apr; 57(2):120-5. PubMed ID: 20601378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
    Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
    Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease.
    Oustamanolakis P; Koutroubakis IE; Messaritakis I; Malliaraki N; Sfiridaki A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):262-8. PubMed ID: 21285884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing anemia in inflammatory bowel disease: beyond the established markers.
    Oustamanolakis P; Koutroubakis IE; Kouroumalis EA
    J Crohns Colitis; 2011 Oct; 5(5):381-91. PubMed ID: 21939910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of serum prohepcidin, iron status and zinc-protoporphyrin in a random group of patients with malignant diseases.
    Grudeva-Popova JG; Terzieva DD; Nenova IS
    J BUON; 2011; 16(2):361-5. PubMed ID: 21766512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transferrin receptor in children and adolescents with inflammatory bowel disease.
    Revel-Vilk S; Tamary H; Broide E; Zoldan M; Dinari G; Zahavi I; Yaniv I; Shamir R
    Eur J Pediatr; 2000 Aug; 159(8):585-9. PubMed ID: 10968236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBD.
    Oustamanolakis P; Koutroubakis IE
    Inflamm Bowel Dis; 2011 Dec; 17(12):E158-9. PubMed ID: 21953900
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum pro-hepcidin levels in infants with iron deficiency anaemia.
    Orhon FS; Ulukol B; Hanoluk A; Akar N
    Int J Lab Hematol; 2008 Dec; 30(6):546-7. PubMed ID: 18983309
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum prohepcidin concentrations in rheumatoid arthritis.
    Jayaranee S; Sthaneshwar P; Sokkalingam S
    Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prohepcidin levels in chronic inflammatory bowel diseases.
    Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
    J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble transferrin receptor and soluble transferrin receptor/log ferritin index in diagnosis of iron deficiency anemia in pediatric inflammatory bowel disease.
    Krawiec P; Pac-Kożuchowska E
    Dig Liver Dis; 2019 Mar; 51(3):352-357. PubMed ID: 30538074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
    Gasche C; Waldhoer T; Feichtenschlager T; Male C; Mayer A; Mittermaier C; Petritsch W;
    Am J Gastroenterol; 2001 Aug; 96(8):2382-7. PubMed ID: 11513178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
    Kovács F; Szakál I; Révész K; Lévai A; Dobos A
    Orv Hetil; 2006 Feb; 147(8):345-9. PubMed ID: 16579333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.
    Marković M; Majkić-Singh N; Subota V
    Scand J Clin Lab Invest; 2005; 65(7):571-6. PubMed ID: 16271988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia.
    Przybyszewska J; Zekanowska E; Kedziora-Kornatowska K; Boinska J; Cichon R; Porzych K
    J Nutr Health Aging; 2011 Apr; 15(4):259-64. PubMed ID: 21437556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.